Digital Exploring the potential of the metaverse in healthcare Immersive experiences could be impactful and valuable to life sciences and healthcare.
Digital AI technology: A game-changer for rare disease diagnosis AI technology isn’t designed to replace clinicians - its function is to help them.
Digital DTx and the case for fit-for-purpose evidentiary standard DTx deliver evidence-based therapeutic interventions driven by high-quality software programs
Digital The connected care horizon in 2023 Some connected care trends expected include digital therapeutics & remote patient monitoring.
Digital Leave no one behind: Digital user research in rare disease Digital solutions have the potential to bridge care gaps for rare disease patients.
Digital Health Innovators – Nigel Brokenshire At the HealthTech X Digitisation of Pharma summit in London in February, pharmaphorum editor-in-chief Jonah Comstock grabbed Nigel Brokenshire, director of UK digital for Bayer, for a quick intervi
News Gilead strikes again, penning $5bn deal to buy Tubulis Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
